Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigational Study of Glycerol Tributyrate in MELAS and LHON-Plus
NCT06792500Phase 2Not yet recruiting
- Sponsor
- George Washington University
- Start
- Mar 2027
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tributyrin in mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS), Leber hereditary optic neuropathy (LHON), sponsored by George Washington University. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
tributyrin
03
Conditions
mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS)Leber hereditary optic neuropathy (LHON)
Beyond the preview
Go deeper on NCT06792500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06792500.